|
1
|
Brun JL, Feyler A, Chêne G, Saurel J, Brun
G and Hocké C: Long-term results and prognostic factors in patients
with epithelial ovarian cancer. Gynecol Oncol. 78:21–27. 2000.
View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Torre LA, Bray F, Siegel RL, Ferlay J,
Lortet-Tieulent J and Jemal A: Global cancer statistics, 2012. CA
Cancer J Clin. 65:87–108. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Muñoz-Casares FC, Rufián S, Arjona-Sánchez
Á, Rubio MJ, Díaz R, Casado Á, Naranjo Á, Díaz-Iglesias CJ, Ortega
R, Muñoz-Villanueva MC, et al: Neoadjuvant intraperitoneal
chemotherapy with paclitaxel for the radical surgical treatment of
peritoneal carcinomatosis in ovarian cancer: A prospective pilot
study. Cancer Chemother Pharmacol. 68:267–274. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Meunier L, Puiffe ML, Le Page C,
Filali-Mouhim A, Chevrette M, Tonin PN, Provencher DM and
Mes-Masson AM: Effect of ovarian cancer ascites on cell migration
and gene expression in an epithelial ovarian cancer in vitro model.
Transl Oncol. 3:230–238. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Moghaddam S Masoumi, Amini A, Morris DL
and Pourgholami MH: Significance of vascular endothelial growth
factor in growth and peritoneal dissemination of ovarian cancer.
Cancer Metastasis Rev. 31:143–162. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Thiery JP: Epithelial-mesenchymal
transitions in tumour progression. Nat Rev Cancer. 2:442–454. 2002.
View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Boyer B, Vallés AM and Edme N: Induction
and regulation of epithelial-mesenchymal transitions. Biochem
Pharmacol. 60:1091–1099. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Vernon AE and LaBonne C: Tumor metastasis:
A new twist on epithelial-mesenchymal transitions. Curr Biol.
14:R719–R721. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Terauchi M, Kajiyama H, Yamashita M, Kato
M, Tsukamoto H, Umezu T, Hosono S, Yamamoto E, Shibata K, Ino K, et
al: Possible involvement of TWIST in enhanced peritoneal metastasis
of epithelial ovarian carcinoma. Clin Exp Metastasis. 24:329–339.
2007. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Drabsch Y and ten Dijke P: TGF-β
signalling and its role in cancer progression and metastasis.
Cancer Metastasis Rev. 31:553–568. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Pickup M, Novitskiy S and Moses HL: The
roles of TGFβ in the tumour microenvironment. Nat Rev Cancer.
13:788–799. 2013. View
Article : Google Scholar : PubMed/NCBI
|
|
12
|
Yu Y, Xiao CH, Tan LD, Wang QS, Li XQ and
Feng YM: Cancer-associated fibroblasts induce
epithelial-mesenchymal transition of breast cancer cells through
paracrine TGF-β signalling. Br J Cancer. 110:724–732. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Giannoni E, Bianchini F, Masieri L, Serni
S, Torre E, Calorini L and Chiarugi P: Reciprocal activation of
prostate cancer cells and cancer-associated fibroblasts stimulates
epithelial-mesenchymal transition and cancer stemness. Cancer Res.
70:6945–6956. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Kenny HA, Krausz T, Yamada SD and Lengyel
E: Use of a novel 3D culture model to elucidate the role of
mesothelial cells, fibroblasts and extra-cellular matrices on
adhesion and invasion of ovarian cancer cells to the omentum. Int J
Cancer. 121:1463–1472. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Kenny HA, Dogan S, Zillhardt M. K..Mitra
A, Yamada SD, Krausz T and Lengyel E: Organotypic models of
metastasis: A three-dimensional culture mimicking the human
peritoneum and omentum for the study of the early steps of ovarian
cancer metastasis. Cancer Treat Res. 149:335–351. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Kajiyama H, Shibata K, Ino K, Nawa A,
Mizutani S and Kikkawa F: Possible involvement of
SDF-1alpha/CXCR4-DPPIV axis in TGF-beta1-induced enhancement of
migratory potential in human peritoneal mesothelial cells. Cell
Tissue Res. 330:221–229. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Kajiyama H, Shibata K, Terauchi M, Ino K,
Nawa A and Kikkawa F: Involvement of SDF-1alpha/CXCR4 axis in the
enhanced peritoneal metastasis of epithelial ovarian carcinoma. Int
J Cancer. 122:91–99. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Sugiyama K, Kajiyama H, Shibata K, Yuan H,
Kikkawa F and Senga T: Expression of the miR200 family of microRNAs
in mesothelial cells suppresses the dissemination of ovarian cancer
cells. Mol Cancer Ther. 13:2081–2091. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Na D, Lv ZD, Liu FN, Xu Y, Jiang CG, Sun
Z, Miao ZF, Li F and Xu HM: Transforming growth factor beta1
produced in autocrine/paracrine manner affects the morphology and
function of mesothelial cells and promotes peritoneal
carcinomatosis. Int J Mol Med. 26:325–332. 2010.PubMed/NCBI
|
|
20
|
Kajiyama H, Kikkawa F, Maeda O, Suzuki T,
Ino K and Mizutani S: Increased expression of dipeptidyl peptidase
IV in human mesothelial cells by malignant ascites from ovarian
carcinoma patients. Oncology. 63:158–165. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Hosono S, Kajiyama H, Terauchi M, Shibata
K, Ino K, Nawa A and Kikkawa F: Expression of Twist increases the
risk for recurrence and for poor survival in epithelial ovarian
carcinoma patients. Br J Cancer. 96:314–320. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Desmoulière A, Guyot C and Gabbiani G: The
stroma reaction myofibroblast: A key player in the control of tumor
cell behavior. Int J Dev Biol. 48:509–517. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Crosas-Molist E, Bertran E and Fabregat I:
Cross-talk between TGF-β and NADPH oxidases during liver fibrosis
and hepatocarcinogenesis. Curr Pharm Des. 21:5964–5976. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Dhanasekaran R, Nakamura I, Hu C, Chen G,
Oseini AM, Seven ES, Miamen AG, Moser CD, Zhou W, van Kuppevelt TH,
et al: Activation of the transforming growth factor-β/SMAD
transcriptional pathway underlies a novel tumor-promoting role of
sulfatase 1 in hepatocellular carcinoma. Hepatology. 61:1269–1283.
2015. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Liu J, Chen S, Wang W, Ning BF, Chen F,
Shen W, Ding J, Chen W, Xie WF and Zhang X: Cancer-associated
fibroblasts promote hepatocellular carcinoma metastasis through
chemokine-activated hedgehog and TGF-β pathways. Cancer Lett.
379:49–59. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Sako A, Kitayama J, Yamaguchi H, Kaisaki
S, Suzuki H, Fukatsu K, Fujii S and Nagawa H: Vascular endothelial
growth factor synthesis by human omental mesothelial cells is
augmented by fibroblast growth factor-2: Possible role of
mesothelial cell on the development of peritoneal metastasis. J
Surg Res. 115:113–120. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Yáñez-Mó M, Lara-Pezzi E, Selgas R,
Ramírez-Huesca M, Domínguez-Jiménez C, Jiménez-Heffernan JA,
Aguilera A, Sánchez-Tomero JA, Bajo MA, Alvarez V, et al:
Peritoneal dialysis and epithelial-to-mesenchymal transition of
mesothelial cells. N Engl J Med. 348:403–413. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Massagué J, Blain SW and Lo RS: TGFbeta
signaling in growth control, cancer, and heritable disorders. Cell.
103:295–309. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Santin AD, Bellone S, Ravaggi A, Roman J,
Smith CV, Pecorelli S, Cannon MJ and Parham GP: Increased levels of
interleukin-10 and transforming growth factor-beta in the plasma
and ascitic fluid of patients with advanced ovarian cancer. BJOG.
108:804–808. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Liao S, Liu J, Lin P, Shi T, Jain RK and
Xu L: TGF-beta blockade controls ascites by preventing
abnormalization of lymphatic vessels in orthotopic human ovarian
carcinoma models. Clin Cancer Res. 17:1415–1424. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Silverman PM: The subperitoneal space:
Mechanisms of tumour spread in the peritoneal cavity, mesentery,
and omentum. Cancer Imaging. 4:25–29. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Pujade-Lauraine E, Hilpert F, Weber B,
Reuss A, Poveda A, Kristensen G, Sorio R, Vergote I, Witteveen P,
Bamias A, et al: Bevacizumab combined with chemotherapy for
platinum-resistant recurrent ovarian cancer: The AURELIA open-label
randomized phase III trial. J Clin Oncol. 32:1302–1308. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Boocock CA, Charnock-Jones DS, Sharkey AM,
McLaren J, Barker PJ, Wright KA, Twentyman PR and Smith SK:
Expression of vascular endothelial growth factor and its receptors
flt and KDR in ovarian carcinoma. J Natl Cancer Inst. 87:506–516.
1995. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Stadlmann S, Amberger A, Pollheimer J,
Gastl G, Offner FA, Margreiter R and Zeimet AG: Ovarian carcinoma
cells and IL-1beta-activated human peritoneal mesothelial cells are
possible sources of vascular endothelial growth factor in
inflammatory and malignant peritoneal effusions. Gynecol Oncol.
97:784–789. 2005. View Article : Google Scholar : PubMed/NCBI
|
